A novel vitamin C analog acts as a potent bio-enhancer to augment the activities of anti-tuberculosis drugs against Mycobacterium tuberculosis
N. P. Bokolia, K. Bag, B. Sarkar, R. Jhawar, D. Chatterji, N. Jayaraman, A. Ghosh
The paper identifies a vitamin C analog, C11, that enhances anti-tuberculosis drug efficacy against M. tuberculosis by reducing mutant generation and increasing ROS production.
bioRxiv · Nov 26, 2023 · PreprintMicrobiology